Are you guy's kidding? Take 2 minutes and review listing requirements for NASDAQ. Even with a R/S and share price at $4.00 how would ADXS qualify without earnings, cash, flow, revenue, market cap, assets, stockholder equity???? It would take YEARS and years.
They meet all of the Nasdaq requirements under standard 3 except the 750K income. Possibly that can be acquired from the deal with fusion vax. Read the minimun requirements for the NASDAQ CM under standard 3.
Who is Aegis Capital? Are they a new underwriter? Anyway, the Company is registering 23+ million shares for offering, which I believe are post-split. Unless I misunderstand, which is quite possible, It appears that they expect to do a secondary shortly after effecting the R/S. Assuming a 1 for 100 R/S, are they registering the equivalent of 2.3 billion new shares? Donja, what say you?
They are saying they are not sure if the Nasdaq capital market will accept their application but if it does they are moving forward with it.
We are offering shares of our common stock and warrants to purchase up to an aggregate of shares of our common stock. The warrants will have a per share exercise price of $ [[125%] of public offering price of the common stock]. The warrants are exercisable immediately and will expire [five] years from the date of issuance. We expect to effect a 1-for- reverse stock split of our issued and outstanding common stock prior to the date of this prospectus.
Our common stock is quoted on the Over-The-Counter Bulletin Board, or OTC Bulletin Board, under the symbol ADXS.OB. We have applied to list our common stock and warrants on The NASDAQ Capital Market under the symbols “ADXS” and “ADXSW,” respectively. No assurance can be given that our application will be approved. On May 14, 2013, the last reported sale price for our common stock on the OTC Bulletin Board was $0.05 per share.